Onconetix, Inc. (ONCO) Insider Trading Disclosures
Onconetix, Inc. (ONCO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ONCO
CIK: 1782107
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MaloneBailey, LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerMariano Frugone
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| ARS | 2026-10-16 | 2025-12-31 | FORM ARS | 0001213900-26-110045 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-07 | 2026-11-10 | DEFINITIVE PROXY STATEMENT | 0001213900-26-107480 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-17 | 2026-09-17 | PRELIMINARY PROXY STATEMENT | 0001213900-26-100837 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-14 | — | CURRENT REPORT | 0001213900-26-099528 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-11 | CURRENT REPORT | 0001213900-26-099524 | View SEC Doc Filr Page |
| 425 | 2026-09-14 | — | FORM 425 | 0001213900-26-099464 | View SEC Doc Filr Page |
| 424B3 | 2026-09-08 | — | PROSPECTUS | 0001213900-26-098126 | View SEC Doc Filr Page |
| EFFECT | 2026-09-03 | — | EFFECT Filing | 9999999995-26-002880 | View SEC Doc Filr Page |
| 425 | 2026-09-03 | — | FORM 425 | 0001213900-26-096951 | View SEC Doc Filr Page |
| S-1/A | 2026-08-31 | — | AMENDMENT NO. 1 TO FORM S-1 | 0001213900-26-095703 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-089093 | View SEC Doc Filr Page |
| S-1 | 2026-08-12 | — | REGISTRATION STATEMENT | 0001213900-26-087986 | View SEC Doc Filr Page |
| 425 | 2026-08-06 | — | FORM 425 | 0001213900-26-085931 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-28 | CURRENT REPORT | 0001213900-26-082879 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0001213900-26-081732 | View SEC Doc Filr Page |
| 425 | 2026-07-07 | — | FORM 425 | 0001213900-26-075776 | View SEC Doc Filr Page |
| 425 | 2026-06-24 | — | FORM 425 | 0001213900-26-071316 | View SEC Doc Filr Page |
| 424B3 | 2026-06-17 | — | PROSPECTUS | 0001213900-26-069508 | View SEC Doc Filr Page |
| EFFECT | 2026-06-16 | — | EFFECT Filing | 9999999995-26-002024 | View SEC Doc Filr Page |
| CORRESP | 2026-06-15 | — | CORRESP Filing | 0001213900-26-068521 | View SEC Doc Filr Page |
| UPLOAD | 2026-06-12 | — | UPLOAD Filing | 0000000000-26-005952 | View SEC Doc Filr Page |
| S-1 | 2026-06-09 | — | REGISTRATION STATEMENT | 0001213900-26-066400 | View SEC Doc Filr Page |
| 8-K | 2026-05-19 | 2026-05-19 | CURRENT REPORT | 0001213900-26-058997 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-13 | CURRENT REPORT | 0001213900-26-056109 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-055483 | View SEC Doc Filr Page |